Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-methyl-dl-trp
2. 1-methyltryptophan
1. 1-methyl-d-tryptophan
2. 110117-83-4
3. D-1mt
4. D-tryptophan, 1-methyl-
5. D-1-methyltryptophan
6. Indoximod (nlg-8189)
7. 1-methyltryptophan
8. D-(+)-1-methyltryptophan
9. Nlg-8189
10. (2r)-2-amino-3-(1-methylindol-3-yl)propanoic Acid
11. (r)-2-amino-3-(1-methyl-1h-indol-3-yl)propanoic Acid
12. 1-methyltryptophan, D-
13. Tx5cyn1kmz
14. Nsc-721782
15. (2r)-2-amino-3-(1-methyl-1h-indol-3-yl)propanoic Acid
16. 1-mt
17. D-l-methyltryptophan
18. D-trp(me)-oh
19. Unii-tx5cyn1kmz
20. Indoximod [usan:inn]
21. Mfcd00274271
22. (2r)-2-azaniumyl-3-(1-methylindol-3-yl)propanoate
23. Indoximod [usan]
24. Nlg 8189
25. 1-methyl-d-tryptophane
26. Indoximod [inn]
27. Indoximod (usan/inn)
28. D-tryptophen, 1-methyl-
29. Indoximod [who-dd]
30. Schembl934800
31. 1-methyl-d-tryptophan, 95%
32. Chembl571209
33. Gtpl8226
34. Zinc39102
35. Dtxsid40911500
36. Indoximod (nlg-8189 Pound(c)
37. Amy22762
38. Bdbm50207089
39. Nsc721782
40. S7756
41. Akos015850753
42. Akos015898463
43. Ccg-266709
44. Cs-4941
45. Db12827
46. Nsc 721782
47. Smp2_000028
48. Ncgc00346842-01
49. Ac-32784
50. As-15999
51. Hy-16724
52. 1-methyl-d-tryptophan (h-d-trp(me)-oh)
53. Db-002380
54. Nlg-8189; D1mt; 1-methyl-d-tryptophan
55. A14397
56. D10640
57. F20545
58. A802144
59. J-002381
60. Brd-k93255255-001-01-3
61. Q27078057
Molecular Weight | 218.25 g/mol |
---|---|
Molecular Formula | C12H14N2O2 |
XLogP3 | -1.3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Exact Mass | 218.105527694 g/mol |
Monoisotopic Mass | 218.105527694 g/mol |
Topological Polar Surface Area | 68.2 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 270 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Indoximod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Indoximod, including repackagers and relabelers. The FDA regulates Indoximod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Indoximod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Indoximod supplier is an individual or a company that provides Indoximod active pharmaceutical ingredient (API) or Indoximod finished formulations upon request. The Indoximod suppliers may include Indoximod API manufacturers, exporters, distributors and traders.
click here to find a list of Indoximod suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Indoximod DMF (Drug Master File) is a document detailing the whole manufacturing process of Indoximod active pharmaceutical ingredient (API) in detail. Different forms of Indoximod DMFs exist exist since differing nations have different regulations, such as Indoximod USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Indoximod DMF submitted to regulatory agencies in the US is known as a USDMF. Indoximod USDMF includes data on Indoximod's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Indoximod USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Indoximod suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Indoximod as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Indoximod API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Indoximod as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Indoximod and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Indoximod NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Indoximod suppliers with NDC on PharmaCompass.
Indoximod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Indoximod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Indoximod GMP manufacturer or Indoximod GMP API supplier for your needs.
A Indoximod CoA (Certificate of Analysis) is a formal document that attests to Indoximod's compliance with Indoximod specifications and serves as a tool for batch-level quality control.
Indoximod CoA mostly includes findings from lab analyses of a specific batch. For each Indoximod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Indoximod may be tested according to a variety of international standards, such as European Pharmacopoeia (Indoximod EP), Indoximod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Indoximod USP).
LOOKING FOR A SUPPLIER?